Glycoconjugation: An approach to cancer therapeutics

doi:10.5306/wjco.v11.i3.110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6818)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

442

WORD

206

HTML

4237

Figures (1-1)

279

Tables (1-1)

209

Sum=5373

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

688

Download

757

Sum=1445

Mar 24, 2020 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Mar 24, 2020; 11(3): 110-120
Published online Mar 24, 2020. doi: 10.5306/wjco.v11.i3.110

Open in New Tab Full Size Figure Download Figure

Figure 1 Glycoconjugation strategy. Different sugar moieties can be conjugated to therapeutic agents, with the aim at improving drug efficiency, including antiproliferative activity and growth inhibition, and upregulating cancer-cell death.

Citation: Molejon MI, Weiz G, Breccia JD, Vaccaro MI. Glycoconjugation: An approach to cancer therapeutics. World J Clin Oncol 2020; 11(3): 110-120
URL: https://www.wjgnet.com/2218-4333/full/v11/i3/110.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i3.110